You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 16, September 18, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Sleep Apnea
 •Alert me on articles by topic

Plasma Levels of Tumor Necrosis Factor {alpha} and Soluble Tumor Necrosis Factor Receptors in Patients With Narcolepsy

Hubertus Himmerich, MD; Pierre A. Beitinger, MD; Stephany Fulda, MSc; Renate Wehrle, MSc; Jakob Linseisen, PhD; Günther Wolfram, MD; Stephanie Himmerich, MSc; Kurt Gedrich, PhD; Thomas C. Wetter, MD; Thomas Pollmächer, MD

Arch Intern Med. 2006;166:1739-1743.

Background  Narcolepsy is a disabling sleep disorder characterized by excessive daytime sleepiness, cataplexy, hypnagogic hallucinations, and sleep paralysis. Recent studies suggest that the immune system might play a pathogenic role pointing to a possible involvement of inflammatory cytokines.

Methods  We investigated a sample of 30 patients with narcolepsy in comparison with 120 sex- and age-matched and 101 sex-, body mass index (BMI)-, and age-matched randomly selected normal controls. In these groups, plasma concentrations of tumor necrosis factor {alpha} (TNF-{alpha}) and its soluble receptors p55 and p75 (soluble TNF receptor [sTNF-R] p55 and sTNF-R p75) were measured using commercial enzyme-linked immunosorbent assays.

Results  The narcoleptic patients showed a significantly higher BMI compared with controls of the same age. Soluble TNF-R p75 levels were consistently elevated in the narcoleptic patients compared with their sex- and age-matched (P = .001) as well as sex-, BMI-, and age-matched counterparts (P = .003). Female narcoleptic patients exhibited higher sTNF-R p55 levels compared with their sex- and age-matched controls (P = .01), but this difference disappeared when comparing patients with sex-, BMI-, and age-matched normal controls. Tumor necrosis factor {alpha} levels did not differ significantly between groups.

Conclusion  Narcoleptic patients show increased plasma levels of sTNF-R p75, suggesting a functional alteration of the TNF-{alpha} cytokine system, further corroborating a possible pathogenic role of the immune system in this sleep disorder.


Author Affiliations: Max Planck Institute of Psychiatry, Munich, Germany (Drs Himmerich, Beitinger, Wetter, and Pollmächer and Mss Fulda and Wehrle); Departments of Human Nutrition and Cancer Prevention (Dr Linseisen), Food and Nutrition (Dr Wolfram), and Consumer Economics (Ms Himmerich and Dr Gedrich), Technical University of Munich, Freising-Weihenstephan, Germany; Division of Clinical Epidemiology, German Cancer Research Center, Heidelberg, Germany (Dr Linseisen); Center of Mental Health, Klinikum Ingolstadt, Ingolstadt, Germany (Dr Pollmächer); and Center for Neurosciences, Klinikum der Philipps–Universität, Klinik für Neurologie Marburg, Germany (Dr Himmerich).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sleep Disturbances Increase Interleukin-6 Production During Pregnancy: Implications for Pregnancy Complications
Okun et al.
Reproductive Sciences 2007;14:560-567.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.